Mark A. Scheideler

PMP22 antisense oligonucleotides reverse Charcot-Marie-Tooth disease type 1A features in rodent models

Hien Zhao, Sagar Damle, Karli Ikeda-Lee et al. · Journal of Clinical Investigation · 2017 · 157 citations · Full text

Medicine, Neurology, Neuroscience +17

Selective expression of regulators of G-protein signaling (RGS) in the human central nervous system

Christopher Larminie, Paul R. Murdock, Jean‐Philippe Walhin et al. · Molecular Brain Research · 2004 · 154 citations

Life Sciences, Neurobiology, Neuroscience +16

Modification of Nociception and Morphine Tolerance by the Selective Opiate Receptor-Like Orphan Receptor Antagonist (–)-cis-1-Methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5 H-benzocyclohepten-5-ol (SB-612111)

Paola Zaratin, Giuseppe Petrone, M. Sbacchi et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 147 citations

Medicine, Medicinal Chemistry, Pharmacology +17

The Cloning and Chromosomal Mapping of Two Novel Human Opioid-Somatostatin-like Receptor Genes, GPR7 and GPR8, Expressed in Discrete Areas of the Brain

Brian F. O’Dowd, Mark A. Scheideler, Tuan Nguyen et al. · Genomics · 1995 · 125 citations · Full text

Life Sciences, Molecular Genetics, Neuroscience +10

Evidence for a Selective Role of the δ-Opioid Agonist [8 R-(4b S*,8aα,8aβ,12bβ)]7,10-Dimethyl-1-methoxy-11-(2-methylpropyl)oxycarbonyl 5,6,7,8,12,12b-hexahydro-(9 H)-4,8-methanobenzofuro[3,2-e]pyrrolo[2,3-g]isoquinoline Hydrochloride (SB-235863) in Blocking Hyperalgesia Associated with Inflammatory and Neuropathic Pain Responses

Paola Petrillo, Ornella Angelici, Sharon Bingham et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 87 citations

Medicine, Neuroscience, Pharmacology +17